HYDROCORTISONE BUTYRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydrocortisone butyrate and what is the scope of patent protection?
Hydrocortisone butyrate
is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Glenmark Pharms Ltd, Taro Pharm Inds, Bausch, Yamanouchi, Precision Dermat, Lupin Ltd, The J Molner, and Taro, and is included in fifteen NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for hydrocortisone butyrate. Six suppliers are listed for this compound.
Summary for HYDROCORTISONE BUTYRATE
US Patents: | 1 |
Tradenames: | 3 |
Applicants: | 9 |
NDAs: | 15 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Clinical Trials: | 4 |
Patent Applications: | 6,799 |
Drug Prices: | Drug price trends for HYDROCORTISONE BUTYRATE |
What excipients (inactive ingredients) are in HYDROCORTISONE BUTYRATE? | HYDROCORTISONE BUTYRATE excipients list |
DailyMed Link: | HYDROCORTISONE BUTYRATE at DailyMed |
Recent Clinical Trials for HYDROCORTISONE BUTYRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Phase 4 |
Peking Union Medical College Hospital | Phase 4 |
Allerderm | Phase 4 |